Arginine vasopressin during cardiopulmonary resuscitation and vasodilatory shock: Current experience and future perspectives

Current Opinion in Critical Care

Volumn 7, Issue 3, 2001, Pages 157-169

  Krismer, Anette C ^a   Wenzel, Volker ^a   Mayr, Viktoria D ^a   Voelckel, Wolfgang G ^a   Strohmenger, Hans U ^a   Lurie, Keith ^b   Lindner, Karl H ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ARGIPRESSIN; CATECHOLAMINE DERIVATIVE;

ARTERIAL PRESSURE; ASYSTOLE; BRAIN OXYGEN CONSUMPTION; DRUG EFFICACY; HEART ARREST; HEART FAILURE; HEART MUSCLE OXYGEN CONSUMPTION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HUMAN; LUNG VENTILATION PERFUSION RATIO; ORGAN BLOOD FLOW; RESUSCITATION; REVIEW; VASODILATATION;

ARGININE VASOPRESSIN; CARDIOPULMONARY RESUSCITATION; EPINEPHRINE; EVIDENCE-BASED MEDICINE; HEART ARREST; HUMANS; SHOCK; UNITED STATES; VASOCONSTRICTION; VASODILATION;

EID: 0034973506     PISSN: 10705295     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075198-200106000-00004     Document Type: Review

References (77)

1. Global neuronal ischemia and reperfusion
2. Special aspects of CPR: Vasopressin as vasopressor, analysis of ventricular fibrillation waveform, and tidal volume in an unintubated patient
3. Guidelines for cardiopulmonary resuscitation and emergency cardiac care
4. The 1998 European Resuscitation Council guidelines for adult advanced life support
5. Failure of epinephrine to improve the balance between myocardial oxygen supply and demand during CPR in dogs
6. Postcountershock pulseless rhythms: Response to CPR, artificial cardiac pacing, and adrenergic agonists
7. Pulmonary ventilation/perfusion defects induced by epinephrine during CPR
8. Is epinephrine contraindicated during cardiopulmonary resuscitation?
9. Epinephrine increases the severity of postresuscitation myocardial dysfunction
10. Epinephrine facilitates cardiac fibrillation by shortening action potential refractoriness
11. High dose and standard dose adrenaline do not alter survival, compared with placebo, in cardiac arrest
12. A randomized clinical trial of high-dose epinephrine and norepinephrine vs. standarddose epinephrine in prehospital cardiac arrest
13. High-dose epinephrine in adult cardiac arrest
14. A comparison of standard and high-dose adrenaline in the resuscitation of asystole and electromechanical dissociation
15. Do advanced cardiac life support drugs increase resuscitation rates from in hospital cardiac arrest?
16. A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital
17. A comparison of standarddose and high-dose epinephrine in cardiac arrest outside the hospital: The Multicenter High-Dose Epinephrine Study Group
18. Cumulative epinephrine dose during cardiopulmonary resuscitation and neurological outcome
19. Über die wirkung der nebennierenextrakte auf herz und blutdruck
20. An experimental research into resuscitation of dogs killed by anaesthetics and asphyxia
21. If one receptor doesn't do it, try another
22. Signal transduction of V1-vascular vasopressin receptors
23. Plasma catecholamine concentrations after successful resuscitation in patients
24. Hemodynamic and metabolic effects of epinephrine during cardiopulmonary resuscitation in a pig model
25. A characterization of hypothalamicpituitaryadrenal axis function during and after human cardiac arrest
26. Stress hormone response during and after CPR
27. Release of endogenous vasopressors during and after cardiopulmonary resuscitation
28. Vasopressin improves vital organ blood flow during closed-chest cardiopulmonary resuscitation in pigs
29. Cerebral oxygenation during cardiopulmonary resuscitation with epinephrine and vasopressin in pigs
30. Effects of repeated doses of vasopressin or epinephrine on mean fibrillation frequency in a porcine model of prolonged cardiopulmonary resuscitation
31. Vasopressin improves vital organ blood flow after prolonged cardiac arrest with postcountershock pulseless activity in pigs
32. Vasopressin combined with epinephrine decreases cerebral perfusion compared with vasopressin alone during cardiopulmonary resuscitation in pigs
33. Epinephrine in cardiac arrest: A critical review
34. Molecular biology of vasopressin receptors
35. Comparison of peptide and nonpeptide receptormediated responses in rat tail artery
36. Endotracheal administration of epinephrine during cardiopulmonary resuscitation
37. Endobronchial vasopressin improves survival during CPR in pigs
38. Endotracheal versus intravenous epinephrine during electromechanical dissociation with CPR in dogs
39. The current status of intraosseous infusion
40. Intraosseous infusions: A flexible option for the adult or child with delayed, difficult, or impossible conventional vascular access
41. Intraosseous vasopressin improves coronary perfusion pressure rapidly during cardiopulmonary resuscitation in pigs
42. Vasopressin decreases endogenous catecholamine plasma levels during CPR in pigs
43. Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care: International consensus on science
44. Repeated administration of vasopressin, but not epinephrine, maintains coronary perfusion pressure after early and late administration during prolonged cardiopulmonary resuscitation in pigs
45. Cardiovascular function during the postresuscitation phase after cardiac arrest in pigs: A comparison of epinephrine versus vasopressin
46. Effect of vasopressin on hemodynamic variables, organ blood flow and acidbase status in a pig model of cardiopulmonary resuscitation
47. Regional blood flow during cardiopulmonary resuscitation in dogs
48. Effects of the AT1 selective angiotensin II antagonist, telmisartan, on hemodynamics and ventricular function after cardiopulmonary resuscitation in pigs
49. Splanchnic and renal blood flow after CPR with epinephrine and vasopressin in pigs
50. Effects of vasopressin and epinephrine on splanchnic blood flow and renal function after cardiopulmonary resuscitation in pigs
51. Effect of smalldose dopamine on mesenteric blood flow and renal function in a pig model of cardiopulmonary resuscitation with vasopressin
52. Improved survival and neurological outcome with vasopressin after prolonged resuscitation in pigs
53. Postresuscitation management
54. Prediction of recovery from posttraumatic vegetative state with cerebral magnetic resonance imaging
55. Vasopressin administration in refractory cardiac arrest
56. A randomized comparison of epinephrine and vasopressin in patients with out-of-hospital ventricular fibrillation
57. Evaluation of the myocardial ischemia subgroup in the vasopressin epinephrine cardiac arrest (VECA) trial
58. Vasopressin can increase coronary perfusion pressure during human cardiopulmonary resuscitation
59. Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care: International consensus on science
60. Vasopressin oder adrenalin bei der therapie des präklinischen herzkreislaufstillstandes: Studienprotokoll einer vergleichenden, multizentrischen, europäischen, blockrandomisierten doppelblindstudie unter der schirmherrschaft des European Resuscitation Council
61. Racial differences in the incidence of cardiac arrest and subsequent survival: The CPR Chicago Project
62. Incidence of cardiac arrest: A neglected factor in evaluating survival rates
63. Outcome of CPR in a large metropolitan area: Where are the survivors?
64. Accuracy of death certificates for coding coronary heart disease as the cause of death
65. Impact of atrial fibrillation on the risk of death: The Framingham Heart Study
66. Cardiac arrest during epidural anesthesia: A comparison between epinephrine and vasopressin in a porcine CPR model
67. Vasopressin improves survival after cardian arrest in hypovolemic shock
68. CPR during severe hypothermia in pigs: Does epinephrine or vasopressin increase coronary perfusion pressure?
69. Comparison of epinephrine and vasopressin in a pediatric porcine model of asphyxial cardiac arrest
70. Vasopressin combined with nitroglycerin increases endocardial perfusion during cardiopulmonary resuscitation in pigs
71. Nitroglycerin enhances vasopressor efficacy during CPR
72. Vasopressin and endothelin during cardiopulmonary resuscitation
73. Effects of vasopressin on left ventricular anterior descending artery blood flow during extremely low cardiac output
74. Vasopressin pressor hypersensitivity in vasodilatory shock
75. A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement
76. Management of vasodilatory shock after cardiac surgery: Identification of predisposing factors and use of a novel pressor agent
77. Refractory vasodilation after cardiopulmonary bypass for heart transplantation in recipients on combined amiodarone and angiotensinconverting enzyme inhibitor therapy: A role for vasopressin administration